only for medical professionals

Servier Laboratories, France

A combined hypotensive drug (BCCC + diuretic)

Tablets with modified release, film-coated, 5 mg + 1.5 mg and 10 mg + 1.5 mg.

diuretic

Tablets, film-coated, 2.5 mg.

Arifon® retard

diuretic

Controlled-release tablets coated with a film coat, 1.5 mg.

Antibiotic polypeptide

Aerosol for topical use dosed, 0.125 mg / release.

Antidepressant

Film-coated tablets, 25 mg.

Venotonizing and venoprotective agent

Tablets, film-coated, 500 mg.

Venotonizing and venoprotective agent

Tablets, film-coated, 1000 mg.

Venotonizing and venoprotective agent

Suspension for oral administration, 1000 mg / 10 ml.

hypoglycemic agent for oral use of the second-generation sulfonylurea group

Modified release tablets 30 mg.

hypoglycemic agent for oral use of the second-generation sulfonylurea group

Modified release tablets 60 mg.

Beta-blockers, other combinations

Film-coated tablets, 5 mg + 25 mg, 7.5 mg + 25 mg, 5 mg + 50 mg, 7.5 mg + 50 mg.

antidepressant, is on the list of III psychotropic substances

Tcovered laths, 12,5 mg.

Packing for hospitals: By 30 tablets in PVC / Al blister. By 1 blister with instruction on medical application in a pack of cardboard from control of the first autopsy.

When packaging (packaging) at LLC "Serdiks":

Packaging for hospitals: 30 tablets each in PVC / Al blister. 1 blister with instruction on medical application in a pack of cardboard from control of the first autopsy.

Antianginal remedy

Pills.

antitumor agent-alkylating compound

Powder for the preparation of a solution for infusions complete with a solvent, 208 mg.

antihypertensive agent combined (diuretic + ACE inhibitor)

Tablets, 2 mg + 0.625 mg.

antihypertensive agent combined (diuretic + ACE inhibitor)

Tablets, film-coated, 2.5 mg + 0.625 mg.

Noliprel® A B-forte

antihypertensive agent combined (diuretic + ACE inhibitor)

Tablets coated with a film membrane, 10 mg + 2.5 mg.

Noliprel® A forte

antihypertensive agent combined (diuretic + ACE inhibitor)

Tablets, film-coated, 5 mg + 1,25 mg.

Noliprel® forte

antihypertensive agent combined (diuretic + ACE inhibitor)

Tablets, 4 mg + 1.25 mg.

Antineoplastic agents, anthracyclines and related substances

Lyophilizate for the preparation of concentrate for the preparation of a solution for infusions, 29 mg.

hypotensive combined agent (angiotensin-converting enzyme (ACE) inhibitor + "slow" calcium channel blocker (BCCC)).

Tablets containing 5 mg perindopril arginine + 5 mg amlodipine, 10 mg perindopril arginine + 10 mg amlodipine, 5 mg perindopril arginine + 10 mg amlodipine, 10 mg perindopril arginine + 5 mg amlodipine.

angiotensin-converting enzyme inhibitor

Tablets of 2 mg. 4 mg

For 14 or 30 tablets per blister (PVC / Al). 1 blister with instructions for use in a pack of cardboard.

Tablets of 8 mg

30 tablets per blister (PVC / Al). 1 blister with instructions for use in a pack of cardboard.

When packaging (packaging) at the Russian company LLC "Serdiks":

Tablets 2 mg and 4 mg.

For 14 or 30 tablets per blister (PVC / Al). 1 blister with instructions for medical use in a pack of cardboard.

Tablets 8 mg.

30 tablets per blister (PVC / Al). 1 blister with instructions for medical use in a pack of cardboard.

inhibitor of angiotensin-converting enzyme (ACE)

Tablets are dispersible in the oral cavity 2.5 mg, 5 mg and 10 mg.

For 30 tablets in a polypropylene bottle, equipped with a dispenser and a stopper containing a moisture absorbing gel.

For 1 bottle of 30 tablets with instructions for medical use in a pack of cardboard with the control of the first autopsy.

Antihypertensive drug combined (β1-adrenoblocker selective + ACE inhibitor)

Tablets, film-coated, 5 mg + 5 mg, 5 mg + 10 mg, 10 mg + 5 mg, 10 mg + 10 mg.

An antiparkinsonian remedy, including a dopaminergic drug.

Controlled-release tablets coated with a coating, 50 mg each.

Hypotensive combination.

Tablets coated with a film coat, 5 mg + 0.625 mg + 2.5 mg, 5 mg + 1.25 mg + 5 mg, 10 mg + 1.25 mg + 5 mg, 5 mg + 2.5 mg + 10 mg, 10 mg + 2.5 mg + 10 mg.

anti-inflammatory anti-bronchoconstrictive agent

Syrup, 2 mg / ml.

anti-inflammatory anti-bronchoconstrictive agent

Tablets, film-coated, 80 mg.